Lykos Therapeutics

MAPS PBC Focuses on Developing and Commercializing Prescription Psychedelics to Bring Better Treatment to Those Suffering from Mental Illnesses. MAPS PBC, Established in 2014, is a Subsidiary of the 501(c)(3) Non-Profit Organization, the Multidisciplinary Association for Psychedelic Studies.